Codexis Inc (NASDAQ: CDXS) kicked off on Monday, up 20.39% from the previous trading day, before settling in for the closing price of $2.55. Over the past 52 weeks, CDXS has traded in a range of $2.43-$6.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 4.02% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 19.10%. With a float of $80.57 million, this company’s outstanding shares have now reached $81.85 million.
In an organization with 188 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 68.36%, operating margin of -98.33%, and the pretax margin is -109.94%.
Codexis Inc (CDXS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Codexis Inc is 2.74%, while institutional ownership is 78.32%. The most recent insider transaction that took place on Mar 21 ’25, was worth 236,266. In this transaction 10% Owner of this company bought 92,923 shares at a rate of $2.54, taking the stock ownership to the 9,250,000 shares. Before that another transaction happened on Mar 20 ’25, when Company’s 10% Owner bought 7 for $2.54, making the entire transaction worth $18. This insider now owns 9,157,077 shares in total.
Codexis Inc (CDXS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.38% during the next five years compared to -33.31% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Take a look at Codexis Inc’s (CDXS) current performance indicators. Last quarter, stock had a quick ratio of 4.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.90, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of Codexis Inc (CDXS)
Let’s dig in a bit further. During the last 5-days, its volume was 1.12 million. That was better than the volume of 0.83 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 38.90%. Additionally, its Average True Range was 0.28.
During the past 100 days, Codexis Inc’s (CDXS) raw stochastic average was set at 17.53%, which indicates a significant decrease from 86.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.10% in the past 14 days, which was higher than the 86.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.86, while its 200-day Moving Average is $3.67. However, in the short run, Codexis Inc’s stock first resistance to watch stands at $3.28. Second resistance stands at $3.49. The third major resistance level sits at $3.81. If the price goes on to break the first support level at $2.75, it is likely to go to the next support level at $2.43. Assuming the price breaks the second support level, the third support level stands at $2.22.
Codexis Inc (NASDAQ: CDXS) Key Stats
The company with the Market Capitalisation of 254.31 million has total of 82,837K Shares Outstanding. Its annual sales at the moment are 59,350 K in contrast with the sum of -65,280 K annual income. Company’s last quarter sales were recorded 21,460 K and last quarter income was -10,380 K.
